Donald Trump & Merck & Co.

Donald Trump: Donald Trump signed the Biosecure Act into law, which restricts federal agencies' business dealings with non-U.S. biotechnology companies, reflecting a broader U.S. policy trend relevant to the current investigations.

Merck & Co.: Merck & Co. is under investigation by the United States — House Select Committee on the Chinese Communist Party for its clinical trials in China, particularly in China — Xinjiang and at military hospitals, raising concerns about national security and ethics. This exposes Merck & Co. to potential reputational damage and regulatory scrutiny.

Merck & Co.: Merck & Co., a hepatitis B vaccine maker, expressed deep concern over the ACIP's vote, and its shares closed down 1.2% on Friday.

Merck & Co.: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.